Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
memo - Magazine of European Medical Oncology
Erschienen in:

01.09.2022 | editorial

Neoadjuvant treatment for solid tumors—the earlier, the better

verfasst von: Univ.-Prof. Dr. Rupert Bartsch, Prof. Dr. Wolfgang Hilbe

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 3/2022

Einloggen, um Zugang zu erhalten

Auszug

Administering adjuvant systemic treatment following local therapy aiming to reduce recurrence rates and mortality is a standard approach in many common malignancies such as breast, colorectal, or lung cancer. Of note, administering systemic treatment already before surgery offers potential additional advantages such as downstaging and downsizing of the primary tumor and regional lymph nodes, in vivo sensitivity testing, earliest possible treatment of potential micrometastatic disease, and response-adapted tailoring of further postoperative therapy. …
Vorheriger Artikel Molecular profiling leading to personalized cancer treatment
Nächster Artikel Real time experience applying CAR T-cells for B-cell lymphoma—What we have learned so far: Acute toxicity management
Literatur
1.
2.
3.
4.
Metadaten
Titel
Neoadjuvant treatment for solid tumors—the earlier, the better
verfasst von
Univ.-Prof. Dr. Rupert Bartsch
Prof. Dr. Wolfgang Hilbe
Publikationsdatum
01.09.2022
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 3/2022
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-022-00835-4

Weitere Artikel der Ausgabe 3/2022

Publisher Correction: Brain metastases: new systemic treatment approaches

  • Open Access
  • Publisher Correction

Molecular profiling in lung cancer

  • Open Access
  • short review

Molecular profiling leading to personalized treatment in breast cancer

  • Open Access
  • short review

Neoadjuvant treatment in gastric cancer

  • short review

CAR T cells in multiple myeloma: Where we stand and where we might be going

  • short review

Applicability of ESMO-MCBS and ESCAT for molecular tumor boards

  • Open Access
  • review